Ligand-specific inhibition of attachment of immune cells to implantable biomaterials
AssigneeThe Children's Hospital of Philadelphia
InventorsStanley J. Stachelek, Dennis Discher, Robert J. Levy, Richard Tsai
Life of this patent
Estimating the term…
Abstract
Methods for protecting biomaterials comprise attaching CD47 or Ig domain thereof to the surface of the biomaterial, thereby inhibiting or reducing immune cell attachment and/or immune cell-mediated damage to the biomaterial. Also provided are kits for practicing these methods and the protected biomaterials.
Claims58
A method for protecting a biomaterial, comprising attaching CD47 or Ig domain thereof to the surface of the biomaterial, wherein the CD47 or Ig domain thereof inhibits or reduces immune cell-mediated damage to the biomaterial.
A method for inhibiting or reducing immune cell attachment to a biomaterial, comprising attaching CD47 or Ig domain thereof to the surface of the biomaterial, wherein the CD47 or Ig domain thereof inhibits or reduces immune cell attachment to the biomaterial.
A biomaterial comprising CD47 or Ig domain thereof attached to the surface of the biomaterial.
Dependencies are inferred from the claim text.